Shareholders to Recover $55 Million in Rare Jury Verdict
DEFA14A
Puma Biotechnology Culture | Comparably
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Barry Simon vs Alan Auerbach | Comparably
Neratinib Improves PFS in HER2+ Metastatic Breast Cancer